Lipidomics: Potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease
- 1 July 2014
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 143 (1), 12-23
- https://doi.org/10.1016/j.pharmthera.2014.02.001
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Lipidomics analysis revealed the phospholipid compositional changes in muscle by chronic exercise and high-fat dietScientific Reports, 2013
- Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitorsBMC Infectious Diseases, 2013
- Shotgun Lipidomics by Sequential Precursor Ion Fragmentation on a Hybrid Quadrupole Time-of-Flight Mass SpectrometerMetabolites, 2012
- MetAlign 3.0: performance enhancement by efficient use of advances in computer hardwareMetabolomics, 2011
- Multi‐dimensional mass spectrometry‐based shotgun lipidomics and novel strategies for lipidomic analysesMass Spectrometry Reviews, 2011
- Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics StudyMetabolomics, 2010
- Effects of sample handling and storage on quantitative lipid analysis in human serumMetabolomics, 2009
- Identification of Lysophosphatidylcholine–Chlorohydrin in Human Atherosclerotic LesionsLipids, 2008
- Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotypeNature Medicine, 2007
- XCMS: Processing Mass Spectrometry Data for Metabolite Profiling Using Nonlinear Peak Alignment, Matching, and IdentificationAnalytical Chemistry, 2006